US Edition
Eyam Health strikes partnership with Swiss non-profit to develop one-dollar malaria treatment
Summary by BetaKit
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Eyam Health strikes partnership with Swiss non-profit to develop one-dollar malaria treatment
Vancouver-based Eyam Health has struck a research partnership with Medicines for Malaria Venture (MMV), a Swiss non-profit that helps develop malaria treatments, to discover a more affordable antimalarial solution. The partnership will use Eyam’s Jennerator platform, which relies on artificial intelligence (AI) to design medications, and its Gemini system (no relation to the Google-owned AI model) to develop and deliver monoclonal antibodies fo…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
